179 related articles for article (PubMed ID: 22559040)
1. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
Omran OM; Ata HS
Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 protein in bilharzial and non-bilharzial bladder cancers.
Gadalla HA; Kamel NA; Badary FA; Elanany FG
BJU Int; 2004 Jan; 93(1):151-5. PubMed ID: 14678388
[TBL] [Abstract][Full Text] [Related]
5. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
Kuncová J; Urban M; Mandys V
APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
9. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
10. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx.
Rodrigo JP; Domínguez F; Alvarez C; González MV; Herrero A; Suárez C
Am J Clin Pathol; 2002 Jul; 118(1):67-72. PubMed ID: 12109858
[TBL] [Abstract][Full Text] [Related]
12. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
14. CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas.
Daniel L; Lechevallier E; Giorgi R; Lindner V; De Fromont M; Vieillefond A; Coulange C; Figarella-Branger D
J Pathol; 2001 Mar; 193(3):345-9. PubMed ID: 11241414
[TBL] [Abstract][Full Text] [Related]
15. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma.
Hong RL; Pu YS; Hsieh TS; Chu JS; Lee WJ
J Urol; 1995 Jun; 153(6):2025-8. PubMed ID: 7538603
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
17. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
[TBL] [Abstract][Full Text] [Related]
20. TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal.
Shaker O; Hammam O; Wishahi M; Roshdi M
Urol Oncol; 2013 Apr; 31(3):372-8. PubMed ID: 21429769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
